Opaleye Management Inc. Aquestive Therapeutics, Inc. Transaction History

Opaleye Management Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$1.54 - $6.75 $1.14 Million - $4.98 Million	-738,500 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$3.06 - $8.78 $2.26 Million - $6.48 Million	738,500 New	738,500 $4.3 Million
Q3 2019 Nov 14, 2019	SELL	$3.04 - $4.91 $1.79 Million - $2.9 Million	-590,000 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$3.72 - $6.95 $2.19 Million - $4.1 Million	590,000 New	590,000 $2.48 Million

121

43.3M

504K

148K

Ticker AQST
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,350,700
Market Cap $152M
Description
Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...

Get notified when there are updates to the investment portfolio of Opaleye Management Inc., based on Form 13F filings with the SEC.

Stay updated on Opaleye Management Inc. with notifications on news.